[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

about

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

Item

http://www.wikidata.org/entity/Q49845401

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

@en

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

@nl

type

Item

label

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

@en

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

@nl

prefLabel

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

@en

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

@nl

P1476

[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

@en

P2093

Berufsverband der Augenärzte Deutschlands e. V.

http://www.w3.org/2001/XMLSchema#string

Deutsche Ophthalmologische Gesellschaft

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Early clinical experience with leflunomide in uveitis

Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA.

Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.

Cyclosporine for ocular inflammatory diseases.

Cyclosporin in the treatment of severe chronic idiopathic uveitis.

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases.

P2888

s00347-017-0582-z

P304

1122-1134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00347-017-0582-Z

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092815941

http://www.w3.org/2001/XMLSchema#string

P698

29159575

http://www.w3.org/2001/XMLSchema#string

P921

uveitis